By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms of Use. I further attest that all information I submit in my employment application is true to the best of my knowledge.

Job Description

About the role:

At Takeda, it's our people, our values and our culture that make us special. We share a sense of vocation and a desire to serve others that pulses through our entire organization. We're fortunate to be grounded in a history that gives us a long term perspective, the confidence to stick to what we believe in, and the humility to know we don't have all the answers. 

We combine this outlook with an agility and tenacity to deliver for our patients that has fueled the growth of our business. But what really sets our company apart is something we call Patient Trust Reputation Business. It's the framework that enables us to translate our purpose and values into action. It's how we synchronize the diversity of our perspectives, strengths and expertise. And it’s what keeps our decision making tethered to what really matters. 

The summer internship program is a full-time commitment of 12 weeks in length and offers a unique perspective into a world-class pharmaceutical company. Our internship program also provides you with the opportunity to network with people at Takeda through various planned events and activities. 

The US Pipeline Evidence Generation and Payer Medical Strategy intern will have the unique opportunity to support two of Takeda’s Value & Evidence Generation teams: (1) New Product Planning Health Economics and Outcomes Research (NPP HEOR) and (2) Value, Access, Insights, & Solutions (VAIS). The US NPP HEOR team is responsible for providing the US voice into product development from Phase 2 to about two years before US launch.  The team works with other US NPP and global cross-functional colleagues to ensure clinical trials and evidence needs (e.g., epidemiology, burden of illness, cost, etc.) align with downstream patient, payer, provider requirements.  The US VAIS team is responsible for payer medical strategy and communication, which includes preparing pipeline products for launch (starting at approximately 2 years prior to product approval), by ensuring payer clinical and health economic needs are met to inform formulary decision making. The VAIS team is also responsible for training the US medical payer-facing field team to ensure launch readiness and field excellence.

Project Outline:

The US Pipeline Evidence Generation and Payer Medical Strategy intern will support the US NPP HEOR team by engaging in a research project to support one or more of Takeda’s pipeline assets in neuroscience, rare disease, dermatology, and/or gastrointestinal disorders.  The research project may include conducting a targeted literature review to inform HEOR study rationale, development/refinement of research question(s) and proposed study methodology, conducting research, analysis and synthesis of research findings, and reporting/discussion of results to the cross-functional team. The intern will understand why the research is being conducted and how the results will be applied to pipeline asset development.

In addition to gaining an understanding of the evidence generation process, the intern will also become familiar with evidence dissemination to the payer customer by supporting the US VAIS team with launch preparation. This engagement may involve assisting with the development of the payer medical value narrative, payer engagement strategy, and rel